Showing results (1201-1210 of 1,258) with videos related to

Sort By:
Pageof 126
Oncotarget|February 9, 2018
Robust diagnosis of Ewing sarcoma by immunohistochemical detection of super-enhancer-driven EWSR1-ETS targetsMichaela C Baldauf, Martin F Orth, Marlene Dallmayer, et al.
BJUI Compass|August 28, 2023
A randomised trial of [18F]PSMA-1007-PET/CT versus NaF-PET/CT for staging primary prostate cancer: A trial protocolKaren Middelbo Buch-Olsen, Mads Hvid Poulsen, Steinbjørn Hansen, et al.
The Journal of Cell Biology|March 16, 2022
A JAM-A-tetraspanin-αvβ5 integrin complex regulates contact inhibition of locomotionDaniel Kummer, Tim Steinbacher, Sonja Thölmann, et al.
The Journal of Clinical Investigation|June 5, 2018
ATR inhibition controls aggressive prostate tumors deficient in Y-linked histone demethylase KDM5DKazumasa Komura, Yuki Yoshikawa, Teppei Shimamura, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 19, 2019
A Novel Mechanism Driving Poor-Prognosis Prostate Cancer: Overexpression of the DNA Repair Gene, Ribonucleotide Reductase Small Subunit M2 (RRM2)Ying Z Mazzu, Joshua Armenia, Goutam Chakraborty, et al.
JCO Global Oncology|April 9, 2021
Tackling Diversity in Prostate Cancer Clinical Trials: A Report From the Diversity Working Group of the IRONMAN RegistryRana R McKay, Theresa Gold, Jelani C Zarif, et al.
ACS Applied Materials & Interfaces|February 19, 2020
10-Fold Quantum Yield Improvement of Ag2S Nanoparticles by Fine Compositional TuningAlicia Ortega-Rodríguez, Yingli Shen, Irene Zabala Gutierrez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 8, 2024
Abiraterone, Olaparib, or Abiraterone + Olaparib in First-Line Metastatic Castration-Resistant Prostate Cancer with DNA Repair Defects (BRCAAway)Maha Hussain, Masha Kocherginsky, Neeraj Agarwal, et al.
International Journal of Cancer|November 17, 2019
Integrative clinical transcriptome analysis reveals TMPRSS2-ERG dependency of prognostic biomarkers in prostate adenocarcinomaJulia S Gerke, Martin F Orth, Yuri Tolkach, et al.
Pageof 126